Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model.

[1]  F. Cabanillas,et al.  Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. , 1991, British journal of cancer.

[3]  J. Nesland,et al.  Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. , 1990, Journal of the National Cancer Institute.

[4]  D. Uebelhart,et al.  Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. , 1990, Bone and mineral.

[5]  R. Baggs,et al.  A murine model of experimental metastasis to bone and bone marrow. , 1988, Cancer research.

[6]  M. Müller,et al.  Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256. , 1988, Oncology.

[7]  R. Rubens,et al.  The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.

[8]  Bijvoet Ol,et al.  Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. , 1986 .

[9]  N. Yuhki,et al.  Metastatic ability and expression of c-fos oncogene in cell clones of a spontaneous rat mammary tumor. , 1986, Japanese journal of cancer research : Gann.

[10]  J. Delaisse,et al.  Bisphosphonates and bone resorption: effects on collagenase and lysosomal enzyme excretion. , 1985, Life sciences.

[11]  P. Meunier,et al.  Inhibition by diphosphonates of bone resorption induced by the Walker tumor of the rat. , 1984, Cancer research.

[12]  P. Reitsma,et al.  Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro. , 1982, The Journal of clinical investigation.

[13]  C. Galasko,et al.  Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins , 1976, Nature.

[14]  C. Galasko.  Mechanisms of bone destruction in the development of skeletal metastases , 1976, Nature.

[15]  H. Bartelheimer.  [Osteoporosis, diagnosis and therapy]. , 1976, Die Medizinische Welt.